NTLA
Intellia Therapeutics, Inc.Company with tickers: NTLA
CIK
1652130
CUSIP
45826J105
Shares Outstanding
139,722,277
13F Activity (30d)
275 filings
263 filers
Price
$12.61
Market Cap
$1.76B
P/E Ratio
-3.31
EPS (Diluted)
$-3.81
52W High
$28.25
52W Low
$6.83
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Type | Date | Period | Action |
|---|---|---|---|
| Earnings Call Transcript | 2025-12-31 | View | |
| Earnings Call Transcript | 2025-09-30 | View | |
| Earnings Call Transcript | 2025-06-30 | View | |
| Earnings Call Transcript | 2025-03-31 | View | |
| Earnings Call Transcript | 2024-12-31 | View | |
| Earnings Call Transcript | 2024-09-30 | View | |
| Earnings Call Transcript | 2024-06-30 | View | |
| Earnings Call Transcript | 2024-03-31 | View | |
| Earnings Call Transcript | 2023-12-31 | View | |
| Earnings Call Transcript | 2023-09-30 | View | |
| Earnings Call Transcript | 2023-06-30 | View | |
| Earnings Call Transcript | 2023-03-31 | View | |
| Earnings Call Transcript | 2022-12-31 | View | |
| Earnings Call Transcript | 2022-09-30 | View | |
| Earnings Call Transcript | 2022-06-30 | View | |
| Earnings Call Transcript | 2022-03-31 | View | |
| Earnings Call Transcript | 2021-12-31 | View | |
| Earnings Call Transcript | 2021-09-30 | View | |
| Earnings Call Transcript | 2021-06-30 | View | |
| Earnings Call Transcript | 2021-03-31 | View | |
| Earnings Call Transcript | 2020-12-31 | View | |
| Earnings Call Transcript | 2020-09-30 | View | |
| Earnings Call Transcript | 2020-06-30 | View | |
| Earnings Call Transcript | 2020-03-31 | View |